MIP and neoplasm: Furthermore, in the ex-vivo DC suppression assay (described in Figure 3B), DCs sorted from MIP treated wild type tumor draining lymph nodes did not exert significant suppression on the tumor-specific T cell proliferation induced by the immunocompetent BMDCs whereas the control wild type DCs strongly suppressed the tumor specific T cell proliferation.